Established in 2004, Institut Pasteur Korea combines biomedical research expertise with information technology to identify molecular targets and discover small molecules for diagnosis, treatment, and addressing unmet health needs. With a strong reputation for groundbreaking research and collaborations worldwide, the institute is a key player in early drug discovery. By integrating biology, IT, and chemistry, Institut Pasteur Korea develops advanced platforms for high content screening and focuses on studying diseases, developing diagnostics, and finding new treatments. With a multinational staff and global partnerships, the institute also tackles antibacterial resistance, viral infections, and cancer, aiming to be one of the premier research institutions in Korea.